ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 330507 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 330507; 2) Community: the network communities that were significantly associated with the response to NSC 330507; 3) Molecule: the relationships between components within communities and NSC 330507; 4) MDR: the compounds that were significantly associated with the NSC 330507.

NSC Compound Enrichment Correlation
NSC 758376 2-(1-(2-fluorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0286383688883668 0.21655573
NSC 763198 Null 0.0286383688883668 0.28206974
NSC 763266 Null 0.0286383688883668 0.18417221
NSC 95382 Camptothecin Derivative 0.0286383688883668 0.074630393
NSC 119621 Null 0.0291420747327558 -0.26438388
NSC 126668 Null 0.0291420747327558 0.0070497832
NSC 134727 MITOMYCIN C 0.0291420747327558 0.31795506
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.0291420747327558 0.41087797
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0291420747327558 0.47673347
NSC 315626 Butyric acid, rhodium salt (4:2) 0.0291420747327558 0.15355315
Total:92  Current:60    [First] [Prev] [Next] [Last]